Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600513 Jiangsu Lianhuan Pharmaceutical
- 10.89
- 0.000.00%
Not Open Dec 13 09:30 CST
3.11BMarket Cap22.41P/E (TTM)
0.00High0.00Low0lotVolume0.00Open10.89Pre Close0.00Turnover0.00%Turnover Ratio23.02P/E (Static)285.46MShares13.0152wk High2.21P/B3.11BFloat Cap6.5652wk Low11.98Limit Up285.46MShs Float23.87Historical High9.80Limit Down0.00%Amplitude0.37Historical Low0.15Dividend TTM--Avg Price0lotAsk1.38%Div YieldTTM100Lot Size0lotBid
Jiangsu Lianhuan Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 10.87%1.64B | 17.98%1.13B | 17.00%528.46M | 11.20%2.17B | 5.04%1.48B | 6.46%954.65M | 11.70%451.68M | 18.80%1.96B | 20.71%1.41B | 18.12%896.69M |
| Operating revenue | 10.87%1.64B | 17.98%1.13B | 17.00%528.46M | 11.20%2.17B | 5.04%1.48B | 6.46%954.65M | 11.70%451.68M | 18.80%1.96B | 20.71%1.41B | 18.12%896.69M |
| Other operating revenue | ---- | -88.06%1.35M | ---- | 34.37%21.46M | ---- | 59.70%11.28M | ---- | 41.36%15.97M | ---- | -18.18%7.06M |
| Total operating cost | 10.54%1.52B | 17.39%1.04B | 16.65%481.82M | 14.26%2.02B | 7.84%1.37B | 9.40%882.11M | 13.55%413.07M | 18.40%1.76B | 20.80%1.27B | 17.97%806.35M |
| Operating cost | 4.89%824.02M | 11.60%552.2M | 13.66%268.77M | 23.62%1.13B | 12.50%785.58M | 11.61%494.79M | 17.01%236.47M | 22.15%912.12M | 22.89%698.32M | 23.61%443.31M |
| Operating tax surcharges | 14.20%14.81M | 20.88%10.55M | 15.30%4.62M | 8.22%19.87M | 3.70%12.97M | 9.47%8.73M | 25.25%4M | 19.59%18.36M | 26.68%12.5M | 26.76%7.98M |
| Operating expense | 17.69%459.17M | 19.98%320.98M | 20.86%142.32M | -2.09%591.6M | 2.73%390.14M | 10.36%267.53M | 8.24%117.76M | 13.52%604.24M | 14.48%379.77M | 9.08%242.41M |
| Administration expense | 9.98%106.06M | 10.69%72.59M | 6.34%42.47M | 2.32%119.52M | -12.40%96.44M | -15.01%65.58M | 3.69%39.94M | 4.90%116.81M | 19.14%110.09M | 17.02%77.16M |
| Financial expense | 2.43%18.23M | -3.26%11.57M | 9.70%5.9M | 24.29%25.48M | 41.72%17.8M | 76.66%11.96M | 26.31%5.38M | 12.68%20.5M | 6.82%12.56M | 1.95%6.77M |
| -Interest expense (Financial expense) | 8.22%18.91M | -6.81%12.12M | -0.95%5.33M | 5.98%26.69M | 3.58%17.47M | 24.64%13.01M | 13.37%5.38M | 31.86%25.18M | 30.15%16.87M | 34.57%10.44M |
| -Interest Income (Financial expense) | 45.08%-582.09K | 45.68%-447.13K | 56.36%-216.13K | 51.48%-1.33M | 51.90%-1.06M | 51.63%-823.1K | 37.56%-495.25K | -41.76%-2.74M | -66.72%-2.2M | -41.23%-1.7M |
| Research and development | 36.61%94.32M | 101.59%67.58M | 86.38%17.74M | 42.95%132.14M | 17.14%69.04M | 16.70%33.52M | 37.90%9.52M | 39.06%92.44M | 50.66%58.94M | 20.69%28.73M |
| Credit Impairment Loss | -1,461.65%-4.98M | -155.76%-2.55M | -292.37%-2.12M | 56.75%-3.71M | 112.32%365.45K | 60.08%-998.27K | 174.81%1.1M | -610.33%-8.59M | -24.99%-2.97M | -19.10%-2.5M |
| Asset Impairment Loss | 23.41%-387.66K | 91.30%-55.11K | 878.09%422.48K | -407.10%-2.56M | -32.79%-506.15K | ---633.69K | ---54.3K | 76.77%-504.03K | ---381.16K | ---- |
| Other net revenue | -191.97%-5.48M | -173.12%-3.61M | -98.40%46.7K | 561.55%16.83M | 388.72%5.96M | 139.11%4.94M | -24.18%2.92M | -595.33%-3.65M | 81.81%1.22M | 533.04%2.07M |
| Invest income | -275.69%-5.62M | -434.00%-4.9M | -100.65%-1.01M | 85.26%-421.81K | 33.26%-1.5M | 7.40%-917.05K | -401.20%-502.85K | -87.82%-2.86M | -136.20%-2.24M | -38.24%-990.31K |
| -Including: Investment income associates | -288.00%-4.54M | -488.77%-3.96M | -16.23%-352.76K | 108.17%138K | 21.99%-1.17M | 0.40%-673.08K | -281.79%-303.5K | -3,355.80%-1.69M | -479.18%-1.5M | -356.52%-675.81K |
| Asset deal income | ---700 | ---- | ---- | 114,520.59%8.89M | ---- | ---- | ---- | ---7.77K | ---- | ---- |
| Other revenue | -27.61%5.5M | -47.98%3.89M | 15.52%2.75M | 76.00%14.64M | 11.59%7.6M | 34.75%7.49M | -53.87%2.38M | 48.06%8.32M | 72.34%6.81M | 78.29%5.56M |
| Operating profit | 4.33%122.48M | 12.62%87.25M | 12.38%46.68M | -6.56%174.77M | -16.93%117.4M | -16.15%77.48M | -6.55%41.54M | 19.72%187.05M | 20.30%141.32M | 21.76%92.4M |
| Add:Non operating Income | -90.17%26.1K | -90.56%25K | -90.54%25K | -45.10%1.78M | 551.56%265.37K | 550.15%264.79K | 593.11%264.29K | -39.03%3.24M | -98.22%40.73K | -97.96%40.73K |
| Less:Non operating expense | -34.71%529.39K | -70.31%208.74K | -23.92%130K | 23.02%1.52M | 19.44%810.88K | 25.74%703.08K | 2.17%170.87K | -37.85%1.24M | 162.57%678.9K | 375.54%559.16K |
| Total profit | 4.39%121.98M | 13.02%87.07M | 11.88%46.58M | -7.42%175.03M | -16.94%116.85M | -16.16%77.04M | -6.06%41.63M | 18.48%189.05M | 17.73%140.68M | 18.14%91.89M |
| Less:Income tax cost | -11.17%14.44M | 54.08%14.39M | 45.77%9.58M | 4.78%23.69M | -19.76%16.26M | -26.08%9.34M | -3.88%6.57M | 15.00%22.61M | 6.85%20.26M | 1.14%12.63M |
| Net profit | 6.90%107.54M | 7.35%72.68M | 5.53%37M | -9.07%151.34M | -16.46%100.6M | -14.58%67.7M | -6.46%35.06M | 18.97%166.44M | 19.78%120.42M | 21.40%79.25M |
| Net profit from continuing operation | 6.90%107.54M | 7.35%72.68M | 5.53%37M | -9.07%151.34M | -16.46%100.6M | -14.58%67.7M | -6.46%35.06M | 18.97%166.44M | 19.78%120.42M | 21.40%79.25M |
| Less:Minority Profit | 26.24%14.84M | 58.61%9.79M | 13.01%4.45M | -34.86%16.33M | -44.38%11.76M | -54.59%6.17M | -44.29%3.94M | 19.04%25.07M | 45.02%21.14M | 24.76%13.6M |
| Net profit of parent company owners | 4.34%92.7M | 2.21%62.89M | 4.58%32.55M | -4.50%135.01M | -10.52%88.84M | -6.29%61.53M | 2.34%31.12M | 18.96%141.37M | 15.50%99.29M | 20.72%65.66M |
| Earning per share | ||||||||||
| Basic earning per share | 3.23%0.32 | 4.76%0.22 | 0.00%0.11 | -4.08%0.47 | -11.43%0.31 | -8.70%0.21 | 0.00%0.11 | 19.51%0.49 | 16.67%0.35 | 21.05%0.23 |
| Diluted earning per share | 3.23%0.32 | 4.76%0.22 | 0.00%0.11 | -4.08%0.47 | --0.31 | -8.70%0.21 | 0.00%0.11 | 19.51%0.49 | ---- | 21.05%0.23 |
| Other composite income | -73.05K | -43.21K | -81.36K | -195.31K | ||||||
| Other composite income of parent company owners | ---73.05K | ---43.21K | ---81.36K | ---195.31K | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 6.83%107.47M | 7.29%72.64M | 5.30%36.92M | -9.19%151.15M | -16.46%100.6M | -14.58%67.7M | -6.46%35.06M | 18.97%166.44M | 19.78%120.42M | 21.40%79.25M |
| Total composite income of parent company owners | 4.26%92.63M | 2.14%62.84M | 4.32%32.46M | -4.64%134.81M | -10.52%88.84M | -6.29%61.53M | 2.34%31.12M | 18.96%141.37M | 15.50%99.29M | 20.72%65.66M |
| Total composite income of minority owners | 26.24%14.84M | 58.61%9.79M | 13.01%4.45M | -34.86%16.33M | -44.38%11.76M | -54.59%6.17M | -44.29%3.94M | 19.04%25.07M | 45.02%21.14M | 24.76%13.6M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
